Q3 EPS Forecast for Oruka Therapeutics Decreased by Analyst
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Free Report) – Research analysts at HC Wainwright cut their Q3 2026 earnings per share (EPS) estimates for shares of Oruka Therapeutics in a report released on Thursday, September 3rd. HC Wainwright analyst M. Kapoor now forecasts that the company will earn ($0.66) per share for the quarter, down from […]
8 Sep 01:13 · The Cerbat Gem